Erlotinib/gefitinibSkin ageing: 3 case reports

被引：0

作者：

机构：

来源：

Reactions Weekly | 2016年 / 1622卷 / 1期

关键词：

D O I：

10.1007/s40278-016-21897-6

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：89 / 89

相关论文

共 50 条

[41] Erlotinib/gefitinibAcneiform eruptions and eruptions: 2 case reports
Reactions Weekly, 2015, 1544 (1) : 104 - 104
[42] Bevacizumab/erlotinib/pembrolizumabVarious toxicities: 9 case reports
Reactions Weekly, 2021, 1879 (1) : 74 - 74
[43] Erlotinib/gefitinibPapulopustular eruption and alopecia: 2 case reports
Reactions Weekly, 2018, 1717 (1) : 130 - 130
[44] Erlotinib/gefitinibRadiation recall pneumonitis: 7 case reports
Reactions Weekly, 2017, 1676 (1) : 128 - 128
[45] Cetuximab/erlotinib/gefitinibAcneiform eruptions: 8 case reports
Reactions Weekly, 2011, 1335 (1) : 14 - 14
[46] GefitinibSkin rash in an elderly patient: case report
Reactions Weekly, 2014, 1495 (1) : 24 - 24
[47] Cetuximab/erlotinib/gefitinibPainful periungual inflammation in elderly patients, treated with adapalene: 3 case reports
Reactions Weekly, 2011, 1379 (1) : 12 - 12
[48] Erlotinib/pembrolizumabLichenoid exanthema, subacute cutaneous lupus erythematosus and papulopustular exanthema: 3 case reports
Reactions Weekly, 2022, 1931 (1) : 259 - 259
[49] Bevacizumab/erlotinib/pemetrexedPlatelets decreased, rash and difficulty in healing surgical incisions: 3 case reports
Reactions Weekly, 2025, 2053 (1) : 70 - 70
[50] Bevacizumab/erlotinib/gefitinibInterstitial lung disease: 5 case reports
Reactions Weekly, 2017, 1653 (1) : 74 - 74

← 1 2 3 4 5 →